Acuitas Scientists Co-Author Nature Article
Acuitas Therapeutics’ Chief Scientific Officer, Dr. Ying Tam, and Director of Formulation Development, Paulo Lin, co-authored (with several other scientists) a study titled “Molecular fate-mapping of serum antibody responses to repeat immunization” that was recently published in Nature. Please click
Acuitas Therapeutics Video Update
Acuitas Therapeutics is the global leader in the field of lipid nanotechnology. We specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles (LNP). We work with partners to develop new therapies to address unmet
Why I Work at Acuitas – Science & Social Fun
The third blog post in our series: “Why I Work at Acuitas” features Research Scientist, Reihaneh Hosseinzadeh. We recently caught up with Ms. Hosseinzadeh and she told us why she chose to work at Acuitas Therapeutics. From as far back as
Why I Work at Acuitas – A Project Manager’s Perspective
Today’s installment in our "Why I Work at Acuitas" series is with Acuitas’ Sr. Associate, Project Manager, Dr. Baishakhi Datta. We recently caught up with Dr. Datta and asked her a few questions about why she chose to work at
Why I Work at Acuitas – A New Series
This is the first post in our new series: "Why I Work at Acuitas." It will highlight some of the incredibly talented, intelligent and innovative people who work at Acuitas – and explain why they have chosen to be a
New Acuitas Therapeutics Video
Acuitas Therapeutics partners with pharmaceutical companies, biotechnology companies and academic institutes to advance nucleic acid therapeutics to the clinic and to the marketplace. After more than a decade of work on our lipid nanoparticle delivery system, it now plays a
A Surreal (and Incredible) Moment in Time
M.D. is a Preclinical Scientist at Acuitas Therapeutics. In early March 2020, President & CEO Dr. Thomas Madden reached out to the Acuitas team and told them that they needed to go home because a global pandemic had just been
We Work Hard and We Play Outside!
The Acuitas Therapeutics team has been working hard over the past 18 months. During the early days of the COVID-19 pandemic, we were focused on working with our partners to develop safe and effective mRNA vaccines, and that meant working
Notes from the Lab – It’s My Job
F.T. is Acuitas Therapeutics’ Lab Manager. Among her many responsibilities is managing all of the communication and general business traffic that comes into Acuitas. She coordinates many elements – making sure that each person has the information they need, the
Notes from the Lab – Doing the Work that Had to Be Done
In early 2020, while much of the world was hunkering down at home as the reality of a global pandemic took hold, A.K., a Research Associate at Acuitas Therapeutics, was busy at work. And not just any work. A.K. was